For research use only. Not for therapeutic Use.
TNG-0746132 can be used for synthesis of the compound with anticancer activity[1].
| Catalog Number | I041281 |
| CAS Number | 2821749-57-7 |
| Synonyms | 2-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-7-[[4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-5H-pyrrolo[3,2-d]pyrimidine |
| Molecular Formula | C26H22F3N7O |
| Purity | ≥95% |
| InChI | InChI=1S/C26H22F3N7O/c1-36-12-19(26(27,28)29)34-24(36)16-5-3-14(4-6-16)9-17-10-30-18-11-31-23(35-21(17)18)20-22(15-7-8-15)32-13-33-25(20)37-2/h3-6,10-13,15,30H,7-9H2,1-2H3 |
| InChIKey | ONJHDRGRJAZAHT-UHFFFAOYSA-N |
| SMILES | CN1C=C(N=C1C2=CC=C(C=C2)CC3=CNC4=CN=C(N=C34)C5=C(N=CN=C5OC)C6CC6)C(F)(F)F |
| Reference | [1]. Throner Scott, et al. Preparation of pyrrolo[3,2-d]pyrimidine compounds and methods of use in the treatment of cancer. World Intellectual Property Organization, WO2022174184 A1. 2022-08-18. |
